SCHEMBL3520138

SCHEMBL3520138

CS(=O)(=O)c1nccc(-c2c(-c3ccc(F)cc3)nc3c[n+]([O-])ccn23)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3524010 0.82 PRKD3 (0.59)
SCHEMBL3520557 0.82 BRAF (0.45)
SCHEMBL3520134 0.82 CSNK1E (0.48)
SCHEMBL14561793 0.79
SCHEMBL4471049 0.79
SCHEMBL14560997 0.78
SCHEMBL14600037 0.78 CSNK1E (0.48)
SCHEMBL1730877 0.78 PRKD3 (0.58)
SCHEMBL3523752 0.78 PRKD3 (0.56)
SCHEMBL3524969 0.78 CSNK1E (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709468-B2 Imidazo based heterocycles ABBOTT LABORATORIES (US) 2010-05-04 US disclosed
US-7709468-B2 Imidazo based heterocycles ABBOTT LABORATORIES (US) 2010-05-04 US disclosed
EP-1928237-A2 NOVEL IMIDAZO BASED HETEROCYCLES Abbott Laboratories (US) 2008-06-11 EP disclosed
US-20070099925-A1 Novel imidazo based heterocycles ABBVIE INC. 2007-05-03 US disclosed
US-20070099925-A1 Novel imidazo based heterocycles ABBVIE INC. 2007-05-03 US disclosed
WO-2007028051-A2 NOVEL IMIDAZO BASED HETEROCYCLES ABBOTT LABORATORIES (US) 2007-03-08 WO disclosed